ORYZON Reports Financial Results and Corporate Updates for Half-Year Ending June 30, 2023
GlobeNewswire
· *Positive aggregate safety data from vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent..
· *Positive aggregate safety data from vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent..